Cardinal Health Inc當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在藥品行業排名32/159位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價214.44。中期看,股價處於上升通道。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。
Cardinal Health Inc評分
相關信息
行業排名
32 / 159
全市場排名
97 / 4592
所屬行業
藥品
壓力支撐
由於公司未披露,未能獲取相關數據
多維評測
本期評分
上期評分
分析師目標
基於
18
分析師
買入
評級
214.444
目標均價
+7.83%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議
Cardinal Health Inc亮點
亮點風險
Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as it owns urology MSO. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The Company connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.
Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as it owns urology MSO. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The Company connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.
公司代碼CAH
公司Cardinal Health Inc
CEOWeitzman (Deborah L)
網址https://www.cardinalhealth.com/en.html
常見問題
Cardinal Health Inc(CAH)的當前股價是多少?
Cardinal Health Inc(CAH)的當前股價是 199.520。
Cardinal Health Inc 的股票代碼是什麼?
Cardinal Health Inc的股票代碼是CAH。
Cardinal Health Inc股票的52週最高點是多少?
Cardinal Health Inc股票的52週最高點是214.930。
Cardinal Health Inc股票的52週最低點是多少?
Cardinal Health Inc股票的52週最低點是114.600。
Cardinal Health Inc的市值是多少?
Cardinal Health Inc的市值是47.49B。
Cardinal Health Inc的淨利潤是多少?
Cardinal Health Inc的淨利潤為1.56B。
現在Cardinal Health Inc(CAH)的股票是買入、持有還是賣出?
根據分析師評級,Cardinal Health Inc(CAH)的總體評級為買入,目標價格為214.444。